Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MST1R | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-05 |
mRNA | SOX9 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-05 |
mRNA | FSTL1 | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-05 |
mRNA | SPHAR | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
mRNA | PRY2 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
mRNA | HAL | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
mRNA | BAHCC1 | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
mRNA | FAM189A1 | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
mRNA | RNF128 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
mRNA | RGS12 | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |